As posted before, we are starting to see the next evolution of cannabis moving from commoditisation to specialist health care solutions. IHL has fully funded trials - note that Cannvalate (also dist for AGH) has chosen to partner with them with options at very high SP. Confidence. The value if these markets like concussion and Sleep Aponea (global problems) are massive and IHL posed to take IP leadership here.
Concussion trials will be very interesting - so topical.
- Forums
- ASX - By Stock
- IHL
- IHL Chart Technicals
IHL Chart Technicals, page-22
-
- There are more pages in this discussion • 157 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)